DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,143,700 | +3.7% | 24,763 | +0.3% | 0.75% | +8.7% |
| Q2 2023 | $5,922,960 | -4.8% | 24,679 | 0.0% | 0.69% | -9.8% |
| Q1 2023 | $6,220,095 | -5.7% | 24,679 | -0.7% | 0.76% | +0.8% |
| Q4 2022 | $6,599,403 | +5.3% | 24,864 | +2.5% | 0.76% | -12.0% |
| Q3 2022 | $6,266,000 | +2.3% | 24,260 | +0.5% | 0.86% | +9.1% |
| Q2 2022 | $6,123,000 | -13.4% | 24,150 | +0.2% | 0.79% | -3.0% |
| Q1 2022 | $7,072,000 | -10.8% | 24,110 | +0.1% | 0.81% | -8.6% |
| Q4 2021 | $7,925,000 | +8.1% | 24,086 | +0.0% | 0.89% | -0.8% |
| Q3 2021 | $7,329,000 | +13.4% | 24,075 | 0.0% | 0.89% | +17.6% |
| Q2 2021 | $6,461,000 | +19.2% | 24,075 | 0.0% | 0.76% | +9.0% |
| Q1 2021 | $5,419,000 | +1.4% | 24,075 | +0.0% | 0.70% | -4.3% |
| Q4 2020 | $5,346,000 | +3.7% | 24,066 | +0.5% | 0.73% | -6.3% |
| Q3 2020 | $5,157,000 | +21.8% | 23,948 | 0.0% | 0.78% | +15.1% |
| Q2 2020 | $4,235,000 | +27.8% | 23,948 | 0.0% | 0.68% | +11.8% |
| Q1 2020 | $3,315,000 | -9.8% | 23,948 | 0.0% | 0.60% | +12.3% |
| Q4 2019 | $3,676,000 | +6.9% | 23,948 | +0.6% | 0.54% | +2.7% |
| Q3 2019 | $3,438,000 | +1.1% | 23,804 | 0.0% | 0.52% | -0.8% |
| Q2 2019 | $3,402,000 | +8.2% | 23,804 | 0.0% | 0.53% | +6.0% |
| Q1 2019 | $3,143,000 | +75.3% | 23,804 | +36.9% | 0.50% | +89.4% |
| Q4 2018 | $1,793,000 | -5.1% | 17,390 | 0.0% | 0.26% | +5.2% |
| Q3 2018 | $1,890,000 | +9.5% | 17,390 | -0.6% | 0.25% | +0.4% |
| Q2 2018 | $1,726,000 | +0.8% | 17,490 | 0.0% | 0.25% | -3.9% |
| Q1 2018 | $1,712,000 | -99.9% | 17,490 | 0.0% | 0.26% | +0.8% |
| Q4 2017 | $1,623,000,000 | +108100.0% | 17,490 | 0.0% | 0.26% | -5.9% |
| Q3 2017 | $1,500,000 | +42.3% | 17,490 | +40.0% | 0.27% | +31.9% |
| Q2 2017 | $1,054,000 | -1.3% | 12,490 | 0.0% | 0.21% | +5.6% |
| Q1 2017 | $1,068,000 | +9.9% | 12,490 | 0.0% | 0.20% | +5.4% |
| Q4 2016 | $972,000 | -0.7% | 12,490 | 0.0% | 0.19% | +2.2% |
| Q3 2016 | $979,000 | +29.5% | 12,490 | +66.8% | 0.18% | +27.3% |
| Q2 2016 | $756,000 | +6.3% | 7,490 | 0.0% | 0.14% | +3.6% |
| Q1 2016 | $711,000 | +2.2% | 7,490 | 0.0% | 0.14% | -7.4% |
| Q4 2015 | $696,000 | +9.1% | 7,490 | 0.0% | 0.15% | +4.2% |
| Q3 2015 | $638,000 | -0.5% | 7,490 | 0.0% | 0.14% | +11.7% |
| Q2 2015 | $641,000 | +0.8% | 7,490 | 0.0% | 0.13% | +2.4% |
| Q1 2015 | $636,000 | -0.9% | 7,490 | 0.0% | 0.12% | -0.8% |
| Q4 2014 | $642,000 | +12.8% | 7,490 | 0.0% | 0.13% | +7.7% |
| Q3 2014 | $569,000 | -3.6% | 7,490 | 0.0% | 0.12% | -5.6% |
| Q2 2014 | $590,000 | +5.0% | 7,490 | 0.0% | 0.12% | +0.8% |
| Q1 2014 | $562,000 | -2.8% | 7,490 | 0.0% | 0.12% | -6.1% |
| Q4 2013 | $578,000 | +11.4% | 7,490 | 0.0% | 0.13% | -0.8% |
| Q3 2013 | $519,000 | +10.9% | 7,490 | +1.2% | 0.13% | +11.9% |
| Q2 2013 | $468,000 | – | 7,400 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |